Epstein-Barr virus LMP2A bypasses p53 inactivation in a MYC model of lymphomagenesis

Kathryn T. Bieging, Alexandra C. Amick, Richard Longnecker*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

35 Scopus citations

Abstract

Although Epstein-Barr virus (EBV) is linked to Burkitt's lymphoma (BL), the role of the virus in lymphomagenesis is unclear. LMP2A, encoded by EBV, can be detected in BL biopsies and has prosurvival functions. We generated mice expressing MYC and LMP2A in B cells. LMP2A/λ-MYC mice show greatly accelerated tumor onset. Similar to previous work, we found p53 mutations in λ-MYC tumors; however, we detected no mutations in the rapidly arising LMP2A/λ-MYC tumors. We further demonstrate that the p53 pathway is functionally intact in LMP2A/λ-MYC tumors, which have increased levels of PUMA and sensitivity to p53 activation by Nutlin. This work shows that LMP2A can permit tumorigenesis in the presence of an intact p53 pathway, identifying an important contribution of EBV to BL.

Original languageEnglish (US)
Pages (from-to)17945-17950
Number of pages6
JournalProceedings of the National Academy of Sciences of the United States of America
Volume106
Issue number42
DOIs
StatePublished - Oct 20 2009

Keywords

  • Apoptosis
  • Burkitt's lymphoma
  • Viral oncogenesis

ASJC Scopus subject areas

  • General

Fingerprint Dive into the research topics of 'Epstein-Barr virus LMP2A bypasses p53 inactivation in a MYC model of lymphomagenesis'. Together they form a unique fingerprint.

Cite this